Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H(1) receptor antagonist properties.

R T Scannell; M P Arrington; L Bayless; X Cai; J B Eckman; M Eckert; D G Ene; J L Ellis; S Hussoin; G M Latham

doi:10.1007/s00011-003-0315-4

Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H(1) receptor antagonist properties.

NobleID: NI8P91W72R82S22
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/3B863EB7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3B863EB7.svg?ark=w1%2F20260515%2F3B863EB7&value=id)](https://nobleid.org/work/w1/20260515/3B863EB7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H(1) receptor antagonist properties.

NobleID: NI8P91W72R82S22
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/3B863EB7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3B863EB7.svg?ark=w1%2F20260515%2F3B863EB7&value=id)](https://nobleid.org/work/w1/20260515/3B863EB7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work